Differentiating Inflammatory Pathways in EGPA and SEA
Study reveals EGPA driven by interferon-mediated inflammation distinct from severe eosinophilic asthma, identifying immune cell signatures and IGF1 pathways as potential therapeutic targets for patients.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.